Poultry Bacteria Infections: Comprehensive Overview of Pathogenesis, Diagnosis, and Antimicrobial Strategies
1. Introduction
Bacterial infections in poultry represent a significant burden on global poultry production, affecting animal welfare, flock productivity, and food safety. The economic impact arises from mortality, reduced growth rates, decreased egg production, and carcass condemnations at slaughter [1, 2]. Several poultry-associated bacteria are zoonotic pathogens, with Salmonella and Campylobacter being leading causes of human foodborne gastroenteritis worldwide [3, 4]. The intensification of poultry production systems, coupled with the global movement of breeding stock, has facilitated the dissemination of bacterial pathogens and their antimicrobial resistance determinants [2]. This article provides a comprehensive overview of the pathogenesis, diagnostic approaches, and antimicrobial strategies for major bacterial infections in poultry, with a focus on the underlying biological mechanisms and current scientific understanding.
2. Major Bacterial Pathogens of Poultry: Pathogenesis and Clinical Syndromes
2.1. Enteric Pathogens: Salmonella and Campylobacter
Salmonellosis in poultry is primarily caused by Salmonella enterica serovars, with S. Enteritidis and S. Typhimurium being the most frequently isolated from clinical cases and poultry products [3]. The pathogenesis of Salmonella infection begins with oral ingestion of the bacterium, followed by colonization of the gastrointestinal tract. The bacteria adhere to intestinal epithelial cells via fimbriae and invade through the M cells of Peyer's patches [3]. Once internalized, Salmonella resides within Salmonella-containing vacuoles (SCVs) and can disseminate to the liver, spleen, and reproductive tract, leading to systemic infection and vertical transmission through eggs [3]. The bacterium employs a type III secretion system (T3SS) encoded by Salmonella pathogenicity island 1 (SPI-1) to inject effector proteins into host cells, inducing cytoskeletal rearrangements and bacterial uptake [3]. A second T3SS, encoded by SPI-2, is essential for intracellular survival and replication within SCVs [3]. In young chicks, infection often results in septicemia and high mortality, whereas in older birds, subclinical carriage is more common, with intermittent fecal shedding [3, 2].
Campylobacter jejuni and Campylobacter coli are the predominant thermophilic Campylobacter species colonizing the poultry intestinal tract [4]. Unlike Salmonella, Campylobacter is a commensal organism in poultry, typically colonizing the cecal and colonic crypts without causing overt disease in the birds [4]. The pathogenesis of colonization involves flagella-mediated motility, which allows the bacterium to penetrate the mucus layer, and multiple adhesins including CadF and FlpA that bind to host extracellular matrix proteins [4]. Campylobacter can also invade intestinal epithelial cells, though this occurs at lower efficiency compared to Salmonella [4]. The high prevalence of Campylobacter in broiler flocks (often exceeding 80% of birds in a colonized flock) is attributed to its ability to form biofilms on water lines and its tolerance to microaerophilic conditions [4]. Horizontal transmission from environmental sources, including contaminated water and litter, is the primary route of flock colonization [2, 4].
2.2. Respiratory and Systemic Pathogens: Mycoplasma Species
Mycoplasma gallisepticum and Mycoplasma synoviae are the most economically significant mycoplasmal pathogens of poultry [5, 6]. M. gallisepticum causes chronic respiratory disease (CRD) in chickens and infectious sinusitis in turkeys, characterized by tracheal rales, coughing, nasal discharge, and airsacculitis [5]. The pathogenesis of M. gallisepticum infection involves attachment to ciliated respiratory epithelial cells via a specialized terminal bleb structure that contains adhesion proteins such as GapA and CrmA [5]. Following attachment, the organism induces ciliostasis, loss of cilia, and desquamation of epithelial cells, leading to impaired mucociliary clearance and secondary bacterial infections, particularly with Escherichia coli [5]. M. gallisepticum employs multiple immune evasion strategies, including antigenic variation of surface lipoproteins, phase variation of the hemagglutinin (VlhA) gene family, and the ability to invade host cells, thereby avoiding antibody-mediated clearance [5]. The organism can also downregulate the host immune response by inducing apoptosis of macrophages and modulating cytokine production [5].
M. synoviae causes infectious synovitis, characterized by inflammation of synovial membranes, tendon sheaths, and bursae, leading to lameness and swollen joints [6]. In addition, M. synoviae is associated with eggshell apex abnormalities (EAA) in laying hens, where the eggshell at the pointed end becomes thin, rough, or cracked [6]. The pathogenesis of M. synoviae involves colonization of the respiratory tract followed by hematogenous dissemination to synovial tissues and the reproductive tract [6]. The synergistic effect of tilmicosin and sinomenine against M. synoviae has been investigated, with the combination showing enhanced inhibition of bacterial growth and biofilm formation compared to either agent alone [6]. The mechanism involves disruption of the bacterial cell membrane and inhibition of protein synthesis, with sinomenine potentiating the effects of tilmicosin by increasing membrane permeability [6].
2.3. Clostridial Diseases: Necrotic Enteritis
Necrotic enteritis (NE) in chickens is caused by Clostridium perfringens type A and, less commonly, type C [7]. The disease manifests in two forms: an acute clinical form characterized by sudden death and severe intestinal necrosis, and a subclinical form that results in reduced growth performance and liver damage (cholangiobepatitis) [7]. C. perfringens is a normal inhabitant of the poultry intestinal tract, but disease occurs only when predisposing factors allow the bacterium to proliferate to high numbers and produce its major virulence factors [7]. The primary predisposing factor is damage to the intestinal mucosa, often caused by coccidial infection (Eimeria spp.), dietary factors such as high levels of non-starch polysaccharides (NSPs), or immunosuppression [7, 2].
The key virulence factor in NE is the NetB toxin, a pore-forming toxin that targets intestinal epithelial cells [7]. NetB binds to the host cell membrane and oligomerizes to form a beta-barrel pore, leading to osmotic lysis and cell death [7]. The resulting necrosis of the intestinal mucosa allows C. perfringens to access nutrients and further proliferate, exacerbating the disease [7]. Other virulence factors include alpha-toxin (phospholipase C), which degrades membrane phospholipids, and various hydrolytic enzymes that contribute to tissue damage [7]. The gut microbiome plays a critical role in NE pathogenesis, with dysbiosis characterized by a reduction in beneficial bacteria such as Lactobacillus and Bifidobacterium and an overgrowth of C. perfringens [2]. The composition of the poultry microbiome is influenced by farm management practices, including feed composition, litter management, and biosecurity measures [2].
2.4. Other Significant Bacterial Pathogens
Escherichia coli, particularly avian pathogenic E. coli (APEC), causes colibacillosis, a complex of diseases including airsacculitis, pericarditis, perihepatitis, and septicemia [1]. APEC strains possess virulence factors such as F1 and P fimbriae for adhesion, aerobactin for iron acquisition, and the Iss protein for serum resistance [1]. Colibacillosis is often secondary to viral or mycoplasmal infections that compromise the respiratory tract, allowing E. coli to invade and disseminate [1].
Pasteurella multocida is the causative agent of fowl cholera, a highly contagious septicemic disease affecting chickens, turkeys, and waterfowl [1]. The pathogenesis involves colonization of the upper respiratory tract followed by invasion of the bloodstream, leading to acute septicemia and death [1]. Virulence factors include the polysaccharide capsule, which inhibits phagocytosis, and lipopolysaccharide (LPS), which triggers a severe inflammatory response [1].
Gallibacterium anatis is an emerging pathogen associated with salpingitis, peritonitis, and oophoritis in laying hens, leading to decreased egg production and increased mortality [1]. The pathogenesis involves adhesion to oviductal epithelium and biofilm formation, which facilitates chronic infection and resistance to antimicrobial therapy [1].
3. Diagnostic Approaches for Poultry Bacterial Infections
3.1. Clinical and Postmortem Examination
Initial diagnosis of bacterial infections in poultry relies on clinical observation and postmortem examination. Clinical signs such as respiratory distress, diarrhea, lameness, and sudden death provide preliminary indications of the disease syndrome [1]. Postmortem lesions, including fibrinous airsacculitis, pericarditis, perihepatitis, and intestinal necrosis, are characteristic of specific bacterial infections [1, 7]. However, definitive diagnosis requires laboratory confirmation due to the overlap of clinical signs and lesions among different pathogens [1].
3.2. Bacteriological Culture and Identification
Conventional culture remains the gold standard for bacterial isolation from poultry samples. Samples are collected from affected tissues (liver, spleen, lung, intestine) or swabs (tracheal, cloacal) and plated on selective and differential media [3]. For Salmonella, pre-enrichment in buffered peptone water followed by selective enrichment in Rappaport-Vassiliadis broth and plating on xylose lysine deoxycholate (XLD) agar is standard [3]. Campylobacter requires microaerophilic conditions (5% O2, 10% CO2, 85% N2) and selective media containing antibiotics to suppress competing flora [4]. Mycoplasma species require specialized media (e.g., Frey's medium) and prolonged incubation (up to 14 days) due to their slow growth [5, 6]. C. perfringens is cultured anaerobically on blood agar or tryptose sulfite cycloserine (TSC) agar [7].
Identification of isolated colonies is based on colony morphology, Gram stain, and biochemical tests. Commercial biochemical test strips and automated identification systems are widely used for species-level identification [3]. However, these methods have limitations, particularly for fastidious organisms like Mycoplasma and for differentiating closely related species [5].
3.3. Molecular Diagnostic Methods
Polymerase chain reaction (PCR) and real-time PCR (qPCR) have become essential tools for the rapid and specific detection of bacterial pathogens in poultry [1, 5, 3]. These methods offer higher sensitivity and specificity compared to culture, and they can detect non-viable organisms, which is advantageous for samples that have been frozen or subjected to antimicrobial therapy [1].
For Salmonella, PCR targeting the invA gene (SPI-1) is widely used for detection, while serovar-specific PCR assays target genes such as sefA (S. Enteritidis) and fliC (S. Typhimurium) [3]. Multiplex PCR assays can simultaneously detect multiple pathogens, including Salmonella, Campylobacter, and C. perfringens, from a single sample [1]. For Mycoplasma species, PCR targeting the 16S rRNA gene or species-specific genes such as mgc2 (M. gallisepticum) and vlhA (M. synoviae) is the method of choice for diagnosis [5, 6]. Quantitative PCR (qPCR) allows for the quantification of bacterial load, which can be correlated with disease severity [5].
Molecular typing methods, including pulsed-field gel electrophoresis (PFGE), multilocus sequence typing (MLST), and whole-genome sequencing (WGS), are used for epidemiological investigations and source tracking [3, 4]. WGS provides the highest resolution for characterizing bacterial strains, identifying virulence genes, and detecting antimicrobial resistance determinants [3].
3.4. Serological Methods
Serological assays, including enzyme-linked immunosorbent assay (ELISA) and serum plate agglutination (SPA) tests, are used for monitoring flock exposure to bacterial pathogens, particularly Mycoplasma and Salmonella [5]. ELISA detects antibodies against specific bacterial antigens and is suitable for large-scale screening of flocks [5]. SPA tests are rapid and inexpensive but have lower specificity and are prone to false-positive reactions [5]. Serological monitoring is an important component of Mycoplasma control programs, as it allows for the identification of infected flocks and the implementation of biosecurity measures [5].
3.5. Diagnostic Workflow
The following Mermaid diagram illustrates a typical diagnostic workflow for poultry bacterial infections.
flowchart TD
A[Clinical Signs / Mortality] --> B[Postmortem Examination]
B --> C["Sample Collection: Tissues, Swabs, Feces"]
C --> D{Diagnostic Pathway}
D --> E[Bacteriological Culture]
D --> F["Molecular Detection: PCR / qPCR"]
D --> G["Serological Testing: ELISA / SPA"]
E --> H["Isolate Identification: Biochemical / MALDI-TOF"]
F --> I[Pathogen Detection & Quantification]
G --> J[Antibody Detection]
H --> K[Antimicrobial Susceptibility Testing]
I --> K
K --> L[Treatment Decision]
H --> M["Molecular Typing: WGS / MLST"]
M --> N[Epidemiological Investigation]
4. Antimicrobial Strategies and Resistance
4.1. Principles of Antimicrobial Therapy
The selection of an antimicrobial agent for treating poultry bacterial infections should be based on the identification of the causative pathogen and its antimicrobial susceptibility profile [1, 3]. Antimicrobial susceptibility testing (AST) is performed using disk diffusion (Kirby-Bauer) or broth microdilution methods, with results interpreted according to clinical breakpoints established by organizations such as the Clinical and Laboratory Standards Institute (CLSI) [3]. The minimum inhibitory concentration (MIC) is the lowest concentration of an antimicrobial that inhibits visible bacterial growth, and it is used to classify isolates as susceptible, intermediate, or resistant [3].
The pharmacokinetic and pharmacodynamic (PK/PD) properties of the antimicrobial must be considered to ensure effective concentrations at the site of infection [1]. For respiratory infections, antimicrobials with good lung tissue penetration, such as tilmicosin and tylosin, are preferred [6]. For enteric infections, antimicrobials that are poorly absorbed from the gastrointestinal tract, such as aminoglycosides, may be used to achieve high local concentrations [3].
4.2. Antimicrobial Resistance Mechanisms
Antimicrobial resistance (AMR) in poultry bacteria is a growing concern, driven by the widespread use of antimicrobials in poultry production [3, 2]. Resistance mechanisms include enzymatic inactivation of the antimicrobial (e.g., beta-lactamases that hydrolyze penicillins and cephalosporins), target site modification (e.g., mutations in DNA gyrase conferring fluoroquinolone resistance), reduced drug accumulation (e.g., efflux pumps that expel tetracyclines), and altered metabolic pathways (e.g., bypass of sulfonamide-inhibited folate synthesis) [3].
In Salmonella, resistance to fluoroquinolones is primarily mediated by mutations in the quinolone resistance-determining regions (QRDRs) of the gyrA and parC genes [3]. Plasmid-mediated quinolone resistance (PMQR) genes, such as qnr, are also emerging [3]. Extended-spectrum beta-lactamase (ESBL) genes, particularly blaCTX-M, confer resistance to third-generation cephalosporins and are often located on mobile genetic elements that facilitate their spread [3]. In Campylobacter, fluoroquinolone resistance is predominantly due to a single point mutation in gyrA (Thr-86-Ile), which is selected rapidly in poultry flocks treated with enrofloxacin [4]. Macrolide resistance in Campylobacter is mediated by mutations in the 23S rRNA gene and ribosomal proteins L4 and L22 [4].
4.3. Alternatives to Conventional Antimicrobials
The need to reduce antimicrobial use in poultry production has driven research into alternative strategies for controlling bacterial infections [7, 2, 6].
Probiotics, prebiotics, and synbiotics are used to modulate the gut microbiome and enhance resistance to pathogen colonization [2]. Probiotics, such as Lactobacillus and Bacillus species, compete with pathogens for adhesion sites and nutrients, produce antimicrobial compounds (bacteriocins), and stimulate the host immune system [2]. Prebiotics, such as mannan-oligosaccharides (MOS) and fructo-oligosaccharides (FOS), selectively promote the growth of beneficial bacteria [2].
Vaccination is a key strategy for preventing bacterial diseases in poultry [7]. For necrotic enteritis, vaccines based on inactivated whole cells, toxoids (NetB toxoid), and recombinant proteins have been developed, with varying degrees of efficacy [7]. Live attenuated vaccines for Salmonella and Mycoplasma are available and used in some production systems [5, 3]. Autogenous vaccines, prepared from specific bacterial isolates recovered from a farm, are used for pathogens such as E. coli and G. anatis [1].
Bacteriophages, viruses that specifically infect and lyse bacteria, are being investigated as alternatives to antibiotics for controlling Salmonella and Campylobacter in poultry [3]. Phage therapy can reduce pathogen colonization in the gastrointestinal tract, but challenges include the narrow host range of phages and the development of bacterial resistance [3].
Antimicrobial peptides (AMPs), including bacteriocins produced by lactic acid bacteria, have shown activity against poultry pathogens [7]. Nisin, a bacteriocin produced by Lactococcus lactis, is effective against C. perfringens and has been used in feed additives to prevent necrotic enteritis [7].
Phytogenic feed additives, derived from plants, contain bioactive compounds such as essential oils, saponins, and flavonoids that have antimicrobial and immunomodulatory properties [6]. The combination of tilmicosin and sinomenine, an alkaloid from the plant Sinomenium acutum, has demonstrated synergistic activity against M. synoviae, suggesting a potential role for phytogenic compounds in enhancing the efficacy of conventional antimicrobials [6].
4.4. Antimicrobial Stewardship in Poultry Production
Antimicrobial stewardship programs aim to optimize antimicrobial use to preserve efficacy while minimizing the selection of resistance [3, 2]. Key principles include: (1) using antimicrobials only when necessary and based on a confirmed diagnosis; (2) selecting the narrowest-spectrum antimicrobial effective against the target pathogen; (3) using appropriate dosages and treatment durations; (4) implementing biosecurity and management practices to reduce the incidence of disease; and (5) monitoring antimicrobial use and resistance patterns [3, 2]. The use of antimicrobials classified as critically important for human medicine, such as fluoroquinolones and third-generation cephalosporins, should be restricted in poultry production to preserve their efficacy for treating human infections [3].
5. Conclusion
Bacterial infections in poultry are caused by a diverse range of pathogens with distinct pathogenic mechanisms, ranging from enteric colonization by Salmonella and Campylobacter to respiratory and systemic infections by Mycoplasma species and clostridial enterotoxemia. Accurate diagnosis requires a combination of clinical, bacteriological, molecular, and serological methods, with molecular techniques providing rapid and specific detection. Antimicrobial therapy must be guided by susceptibility testing and PK/PD principles, and the growing threat of antimicrobial resistance necessitates the adoption of alternative control strategies, including vaccination, probiotics, and phage therapy. Integrated disease management approaches that combine biosecurity, vaccination, and antimicrobial stewardship are essential for sustainable poultry production and the protection of public health.
References
[1] Liu H, Pan S, Wang C, et al. Review of respiratory syndromes in poultry: pathogens, prevention, and control measures. Vet Res. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40382667/
[2] Xu X, Rothrock MJ Jr, Mishra A, et al. Relationship of the Poultry Microbiome to Pathogen Colonization, Farm Management, Poultry Production, and Foodborne Illness Risk Assessment. J Food Prot. 2023. URL: https://pubmed.ncbi.nlm.nih.gov/37774838/
[3] Lamichhane B, Mawad AMM, Saleh M, et al. Salmonellosis: An Overview of Epidemiology, Pathogenesis, and Innovative Approaches to Mitigate the Antimicrobial Resistant Infections. Antibiotics (Basel). 2024. URL: https://pubmed.ncbi.nlm.nih.gov/38247636/
[4] Kaakoush NO, Castaño-Rodríguez N, Mitchell HM, et al. Global Epidemiology of Campylobacter Infection. Clin Microbiol Rev. 2015. URL: https://pubmed.ncbi.nlm.nih.gov/26062576/
[5] Liu Y, Wang Y, Zheng SJ. Immune Evasion of Mycoplasma gallisepticum: An Overview. Int J Mol Sci. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/38474071/
[6] Deng B, Wang X, Li M, et al. A novel therapeutic strategy for Mycoplasma synoviae infection: Elucidating the synergistic effects and underlying mechanisms of Tilmicosin and Sinomenine. Poult Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42308745/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.
[7] Shamshirgaran MA, Golchin M. Necrotic enteritis in chickens: a comprehensive review of vaccine advancements over the last two decades. Avian Pathol. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/39190009/
[8] Atasoy MO, Turan T, Yelken SD, et al. Widespread gyrovirus co-infections in backyard chickens in Türkiye: molecular and Phylogenetic insights. Vet Res Commun. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42068397/